Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood insulin amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000358,serum insulin level,,,,0.000316,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67477,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood free fatty acid amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,218 days,11,,CMO:0000547,serum free fatty acids level,,,,0.66,mmol/l,0.048,0.1592,MMO:0000308,serum free fatty acid analysis,,0.0,"Wako Pure Chemicals, Tokyo, Japan",,,days,specific pathogen-free condition (for 210 days) then fasting (for 1 days),67497,specific pathogen-free condition (for 210 days),fasting (for 1 days), 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",epididymal fat pad mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,218 days,11,,CMO:0000658,epididymal fat pad weight to body weight ratio,,,,2.49,%,0.06,0.199,MMO:0000005,post excision weight measurement,,0.0,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),67493,specific pathogen-free condition (for 210 days),fasting (for 1 days), 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",epididymal fat pad mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,175 days to 168 days,12,,CMO:0000658,epididymal fat pad weight to body weight ratio,,,,2.1,%,0.1,0.3464,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,97743,control condition,, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",retroperitoneal fat pad mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,218 days,11,,CMO:0000635,retroperitoneal fat pad weight to body weight ratio,,,,2.47,%,0.09,0.2985,MMO:0000005,post excision weight measurement,,0.0,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),67473,specific pathogen-free condition (for 210 days),fasting (for 1 days), 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",retroperitoneal fat pad mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,175 days to 168 days,12,,CMO:0000635,retroperitoneal fat pad weight to body weight ratio,,,,2.5,%,0.18,0.6235,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,97735,control condition,, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",retroperitoneal fat pad mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,218 days,11,,CMO:0000356,retroperitoneal fat pad weight,,,,10.5,g,0.4,1.3266,MMO:0000005,post excision weight measurement,,,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),12795,specific pathogen-free condition (for 210 days),fasting (for 1 days), 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",retroperitoneal fat pad mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,175 days to 168 days,12,,CMO:0000356,retroperitoneal fat pad weight,,,,7.81,g,0.41,1.4203,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,97723,control condition,, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood glucose amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000046,blood glucose level,,,,82.5,mg/dl,3.5,11.6082,MMO:0000113,oral glucose tolerance test,,0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12792,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood triglyceride amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,218 days,11,,CMO:0000360,serum triglyceride level,,,,113.5,mg/dl,4.81,15.953,MMO:0000136,serum triglyceride analysis,,0,"Wako Pure Chemicals, Tokyo, Japan",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),13194,specific pathogen-free condition (for 210 days),fasting (for 1 days), 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",blood triglyceride amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,175 days to 168 days,7,,CMO:0000360,serum triglyceride level,,,,80.54,mg/dl,8.04,21.2718,MMO:0000136,serum triglyceride analysis,,0.0,"TG-E test kits, Wako Chem. Ltd. Osaka, Japan",,,,control condition,97751,control condition,, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",mesenteric fat pad mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,218 days,11,,CMO:0000355,mesenteric fat pad weight,,,,8.8,g,0.4,1.3266,MMO:0000005,post excision weight measurement,,,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),12794,specific pathogen-free condition (for 210 days),fasting (for 1 days), 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",mesenteric fat pad mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,175 days to 168 days,5,,CMO:0000355,mesenteric fat pad weight,,,,5.23,g,0.57,1.2746,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,97727,control condition,, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood cholesterol amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,218 days,11,,CMO:0000363,serum total cholesterol level,,,,72.7,mg/dl,2.13,7.0644,MMO:0000132,serum total cholesterol measurement test,,0.0,"Wako Pure Chemicals, Tokyo, Japan",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),12793,specific pathogen-free condition (for 210 days),fasting (for 1 days), 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",blood cholesterol amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,175 days to 168 days,7,,CMO:0000363,serum total cholesterol level,,,,42.69,mg/dl,5.25,13.8902,MMO:0000132,serum total cholesterol measurement test,,0.0,"T-CHO-E test kits, Wako Chem. Ltd. Osaka, Japan",,,,control condition,97747,control condition,, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",epididymal fat pad mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,218 days,11,,CMO:0000357,epididymal fat pad weight,,,,10.6,g,0.3,0.995,MMO:0000005,post excision weight measurement,,,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),12796,specific pathogen-free condition (for 210 days),fasting (for 1 days), 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",epididymal fat pad mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,175 days to 168 days,12,,CMO:0000357,epididymal fat pad weight,,,,6.45,g,0.27,0.9353,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,97731,control condition,, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",body mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000012,body weight,,,,425.3,g,5.3,17.5781,MMO:0000016,body weighing method,,0.0,,oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12797,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",mesenteric fat pad mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,218 days,11,,CMO:0000654,mesenteric fat pad weight to body weight ratio,,,,2.06,%,0.09,0.2985,MMO:0000005,post excision weight measurement,,0.0,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),67469,specific pathogen-free condition (for 210 days),fasting (for 1 days), 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",mesenteric fat pad mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,175 days to 168 days,5,,CMO:0000654,mesenteric fat pad weight to body weight ratio,,,,1.7,%,0.13,0.2907,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,97739,control condition,, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood adiponectin amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000583,serum adiponectin level,,,,3.02,ng/ml,0.15,0.4975,MMO:0000075,enzyme linked immunosorbent assay,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),67481,specific pathogen-free condition (for 210 days),fasting (for 1 days), 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood leptin amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000780,serum leptin level,,,,6.28,ng/ml,0.51,1.6915,MMO:0000075,enzyme linked immunosorbent assay,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,7,days,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67485,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",body mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,175 days to 168 days,22,,CMO:0000012,body weight,,,,301.64,g,7.17,33.6303,MMO:0000016,body weighing method,,0.0,,,,,control condition,97719,control condition,, 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",adipocyte free fatty acid secretion trait,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,175 days to 168 days,7,,CMO:0000876,adipocyte basal free fatty acid secretion,,,,0.39,mEq/l,0.03,0.0794,MMO:0000246,lipolysis assay measuring free fatty acid release,,0.0,"NEFA-C test kits, Wako Chem. Ltd. Osaka, Japan",,,,control condition,97755,control condition,,